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Pro vysokou incidenci a potenciální závažnost představují 
alergická onemocnění jeden z klíčových problémů imunologie 
21. století. Přesto v poznání časných mechanismů, podílejících 
se na rozvoji alergie, existují významné mezery. Aby bylo u 
rizikových jedinců možné přistoupit k časným preventivním 
opatřením, je třeba zavést spolehlivější prediktory rizika 
alergie. 
Podkladem alergie je nerovnováha mezi větvemi imunitní 
reakce, především nežádoucí převaha Th2 odpovědi. Regulační 
T lymfocyty (Treg) zodpovídají za jemné nastavování 
rovnováhy imunitního systému i periferní toleranci vůči 
alergenům. Časně postnatálně má na vývoj imunitního systému 
výrazný vliv kolonizující mikrobiota. Slibným přístupem v 
prevenci alergie je proto podávání probiotik za účelem podpory 
fyziologického vývoje mikrobioty a imunitního systému. 
V naší studii jsme pozorovali snížení znaků souvisejících 
s regulační funkcí Treg a nižší produkci IL-10 v pupečníkové 
krvi novorozenců alergických matek, u této skupiny dětí byla 
rovněž nižší proporce Helios- indukovaných Treg. Tyto nálezy 
odrážejí opožděnou funkční maturaci Treg, která může vést k 
vyššímu riziku rozvoje alergie a pravděpodobně též zodpovídá 
za vyšší reaktivitu dendritických buněk (DC), kterou jsme u této 
skupiny pozorovali. 
Ve věku 8 let jsme zaznamenali snížení incidence alergie u 
dětí alergických matek, kterým byl po narození podán 
probiotický kmen E. coli O83:K24:H31 (EcO83). Biologický 
efekt byl daný pravděpodobně normalizací produkce IL-10 a 
IFN-γ a podporou imunoregulačních mechanismů. V in vitro 
studiích jsme po stimulaci buněk pupečníkové krve EcO83 
potvrdili zvýšení produkce IL-10 a IFN-γ a zvýšenou indukci 
IL-10+ CD4+ u T buněk kokultivovaných se stimulovanými DC. 
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Due to high incidence and impact, allergic disorders are a 
crucial issue for 21st century immunology. Much still remains 
to be elucidated regarding very early processes in allergy 
development. In order to introduce timely preventive measures, 
novel predictive factors of allergy risk need to be established. 
Allergy is caused by dysregulation of balance between 
immune response branches, chiefly unwarranted Th2 
dominance. Regulatory T cells (Treg) are crucial for finely 
setting immune balance and inducing tolerance towards 
allergens. Early postnatally, interaction with microbiota 
modulates immune development. Supplementation with 
probiotic bacteria to support physiological microbiota and 
immune development is thus a potentially promising approach 
for allergy prevention. 
We observed decreased presence of function-associated 
surface markers and lower IL-10 production in cord blood Treg 
of children of allergic mothers, as well as a decreased 
proportion of Helios- induced Treg. These findings hint at 
delayed functional maturation of Treg in the high-risk group, 
consistent with observation of increased dendritic cell (DC) 
reactivity of these children. 
Early postnatal colonisation with probiotic E. coli strain 
O83:K24:H31 (EcO83) reduced allergy incidence in colonised 
children of allergic mothers at the age of 8 years, likely owing 
to normalisation of IL-10 and IFN-γ production. This effect may 
also be due to promotion of regulatory responses. Upon in vitro 
stimulation with EcO83, we observed increase in production of 
IL-10 and IFN-γ by CBMC, higher ability of DC to produce 
IL-10 and higher induction of IL-10+ CD4+ T cells in coculture 
with the stimulated DC. 





Allergy represents a heterogeneous group of disorders with 
collectively high incidence, characterised by unwarranted immune 
response toward harmless external antigens, i.e. allergens. Both genetic 
predisposition and environmental factors contribute to allergy 
development. 
While there are many options for symptomatic treatment of allergy, 
causal therapy of allergic diseases and especially effective predictive and 
preventive measures remain limited, with maternal or biparental allergy 
positivity being the strongest predictors of high risk of allergy 
development1,2. Research into the early processes involved in allergy 
pathogenesis thus continues to be of crucial importance in immunology. 
Underlying cause of allergy is a dysregulation of immune system 
balance, mainly undue dominance of Th2. Over the majority of prenatal 
period, Th2 bias is maintained to prevent unwanted Th1 or Th17 immune 
reactions at the maternal-foetal interface3. After birth, immune system 
needs to rebalance to prepare the neonate for adequate reactivity towards 
newly encountered environmental stimuli. 
Regulatory T cells (Treg) play a central role in finely setting this 
balance and inducing as well as maintaining tolerance towards allergens4. 
Human Treg are defined as CD4+CD25highCD127low cells with high 
expression of lineage-specific transcription factor FoxP3, characteristic 
epigenetic regulation and ability to efficiently suppress and modulate 
immune reactions both in local, antigen-specific manner and in a broader, 
more distal fashion, such as by producing IL-10 and TGF-β. Treg can be 
divided into various subpopulations of different tissue and biological 
context, chiefly into Helios+ thymically generated natural Treg (nTreg) 
with self-antigen specific T-cell receptor (TCR) or Helios- peripherally 
induced Treg (iTreg) with TCR specific for environmental antigens5. In 
the context of allergy, other regulatory cell types can play important roles, 
including CD4+FoxP3- type 1 Treg (Tr1) and regulatory B lymphocytes 
(Breg), both of which produce very high amounts of IL-10 and are 
indispensable for the success of allergen-specific immunotherapy, the 
sole causal treatment option used in allergy6. 
Interactions with external factors, most importantly microbiota, exert 
large influence on the developing immune system, particularly during the 
early postnatal “window of opportunity7.” Factors such as composition, 
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diversity, metabolic activity and spatiotemporal properties of exposure to 
symbiotic, commensal and pathogenic microbes play a key role in the 
induction of or protection from numerous immune-related, inflammatory 
disorders, including allergy8. Major theories including the “hygiene 
hypothesis” and “old friends” hypothesis9 have proposed dysregulation 
of microbiota (termed dysbiosis) as the major factor behind the extreme 
rise in incidence of non-communicable inflammatory diseases, including 
allergy, in the developed countries over the last century. 
Supplementation with probiotic bacteria is considered a potentially 
promising approach for allergy prevention. Probiotics can promote 
immune maturation and support regulation in numerous ways, depending 
on the strain used and the particulars of its administrations. Usefulness of 
probiotics in allergy prevention is currently hotly debated, with combined 
prenatal and postnatal supplementation proposed as most likely to be 
useful in atopic eczema prevention10. In our studies, we observed the 
effect of probiotic bacterium Escherichia coli strain O83:K24:H31 on 
allergy development in high-risk children at the age of 8 years, as well as 
its effect on cells derived from cord blood of children in vitro. 
2. Aims 
2.1. First major aim was to characterise Treg cell populations involved in 
immune regulation during the perinatal period and to evaluate their 
potential usefulness in allergy prediction. In particular, we aimed to: 
a) Compare proportions of CD4+CD25highFoxP3+ total Treg and their 
subpopulations, FoxP3+Helios+ nTreg and FoxP3+Helios- iTreg, in 
cord blood of children of allergic mothers and children of healthy 
mothers.  
b) Compare surface presence of markers associated with regulatory 
function, intracellular presence of regulatory cytokines and 
suppressive function of cord blood Treg of children of allergic 
mothers and children of healthy mothers. 
c) Evaluate cord blood Treg proportions and presence of selected 
function-associated markers in the context of clinical allergy 
development during childhood. 
2.2. Second major aim was to describe the effect of probiotic strain E. coli 
O83:K24:H31 on cell populations in the context of allergy in order to 
uncover the possible mechanisms behind the ability of this probiotic 
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strain to decrease allergy incidence in the high-risk group. In particular, 
our aims were to: 
a) Analyse the influence of early postnatal EcO83 supplementation of 
children of allergic mothers on allergy development and sensitization 
and Treg, nTreg and iTreg population proportions at the age of 8 
years. 
b) Evaluate the influence of early postnatal EcO83 supplementation of 
children of allergic mothers on IL-10 production by Treg and 
CD4+FoxP3- Tr1 cells and plasma levels of key cytokines (IL-4, 
IL-10 and IFN-γ) at the age of 8 years. 
c) Determine in vitro the influence of EcO83 on CBMC and CBMC-
derived moDC to assess EcO83-elicited cytokine production and DC 
maturation. 
3. Materials and methods 
Subjects and sample collection 
Healthy and allergic mothers with physiological pregnancies 
delivering at full term in the Institute for the Care of the Mother and Child 
in Prague were included for the study. Allergy status of the mother was 
determined based on clinical manifestation of allergy persisting for at 
least 24 months; allergy against respiratory and/or food allergens 
manifested by various individual combinations of symptoms (e.g. hay 
fever, conjunctivitis, eczema, bronchitis, asthma etc.), monitoring by an 
allergist, positive skin prick tests or positive specific IgE and anti-allergic 
treatment before pregnancy. The study was approved by the Ethical 
Committee of the Institute for the Care of Mother and Child, Prague, 
Czech Republic, and was carried out with a signed written informed 
consent of the mothers. 
Cord blood (CB) samples (approx. 10-20 ml) were collected into 
sterile heparinized tubes immediately after birth for cell analysis by flow 
cytometry. CB plasma was obtained for cytokine detection.  
Allergy status of 8-year-old children was followed by allergist 
(parents reports of allergy manifestation was confirmed either by positive 
skin prick tests and/or positive specific IgE antibodies). Peripheral blood 
(PB) was collected for cell analysis by flow cytometry. PB plasma was 




Flow cytometry analysis of regulatory T cells 
Cord blood samples were prepared and stained for flow cytometry as 
described previously11. Briefly, samples of whole cord blood were stained 
with antibodies against Treg surface markers CD4, CD25 and CD127. 
Staining and sample preparation were performed according to 
manufacturer’s instructions using human regulatory T cell whole blood 
staining kit (eBioscience). After fixation and permeabilization, the 
samples were stained with antibodies against Treg intracellular markers 
FoxP3 and Helios. In some experiments, non-stimulated whole blood 
samples were stained for the following surface markers associated with 
Treg function: CTLA-4, PD-1, GITR. Non-stimulated whole blood 
samples treated with BD GolgiPlug (Becton Dickinson) for 6 hours were 
permeabilized after surface staining for Treg and stained for intracellular 
expression of regulatory cytokines IL-10 and TGF-β. Proportion of Treg 
in peripheral blood of 8-year-old children was determined using 
TregFlowEx Kit (Exbio) optimized for detection of Treg in heparinized 
whole blood. Gating strategies described previously11 were used. 
Flow cytometry data were acquired on a BD FACSCanto flow 
cytometer using BD FACS Diva version 6.1.2 software (Becton 
Dickinson) and analysed using FlowJo 7.2.2. (TreeStar). 
CBMC isolation, culture and in vitro stimulation with EcO83 
Cord blood mononuclear cell fraction (CBMC) was obtained from 
whole cord blood by density gradient centrifugation (Histopaque-1077; 
Sigma-Aldrich) for downstream culture-based assays and RNA isolation. 
To characterize the effect of EcO83 on neonatal immune system, CBMC 
were stimulated by EcO83 in vitro and cytokines typical for Th1 (IFN-γ), 
Th2 (IL-4) and Treg (IL-10) were detected by qPCR and ELISA. The 
capacity of EcO83 to promote Treg induction was tested by flow 
cytometry. The capacity of EcO83 to induce immune response was 
compared with other probiotic strain E. coli Nissle 1917 (EcN) (kindly 
provided by Ulrich Sonnenborn, ArdeyPharm). LPS (1 μg/ml, 
Escherichia coli, Sigma) was used as a control. 
Dendritic cell generation and in vitro stimulation with EcO83 
Dendritic cells (monocyte derived dendritic cells; moDC) were 
derived from adherent fraction of CBMC as described previously12. 
Briefly, after 1 h cultivation of CBMC in cell culture flasks in the 
incubator with regulated CO2 atmosphere, nonadherent CBMC were 
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washed out and adherent CBMC were cultured for 6 days with 
recombinant human (rh) IL-4 and rhGM-CSF. In vitro generated moDC 
were seeded on day 6 at a concentration of 1 × 106 cells/ml in 12-well 
plates and stimulated with LPS (1 μg/ml, Escherichia coli, Sigma), 
or probiotic bacteria E. coli O83:K24:H31 in the ratio of 10 bacterial cells 
to 1 moDC for 24 h. Maturation status after stimulation was estimated 
according to the presence of activation markers (CD40, CD80, CD83, 
CD86, MHCII) on moDC by flow cytometry. 
Flow cytometry analyses of immune responses induced by moDC 
Intracellular staining of transcription factors and cytokines typical for 
Th1 (T-bet; IFN-gamma), Th2 (GATA3; IL-4, IL-13), Th17 (RORgt; 
IL-17A, IL-22) and Tregs (FoxP3; IL-10) was performed after cell 
surface staining by antibody against CD4 for 20 min, then washed twice 
with PBS containing 1% BSA, followed by fixation and permeabilization 
(BD Pharmingen Transcription Factors Buffer Set) according to the 
manufacturer’s recommendation.  
Cytokine concentration in cord blood and peripheral blood plasma 
and cell culture supernatants 
Cytokines in plasma of cord blood or peripheral blood of 8-year-old 
children and cytokines released by non-stimulated and stimulated 
cultured CBMC or moDC were detected by ELISA (reagents obtained 
from R&D Systems). The results were read from calibration curve in 
picograms per millilitre. 
Relative quantification of gene expression 
Total RNA was isolated from CBMC or in vitro generated moDC 
using RNeasy Mini Kit (Qiagen) followed by reverse transcription. Gene 
expression of cytokines (IL-4, IL-10, IFN-γ) and indolamine 
2,3-dioxygenase (IDO) was estimated by quantitative real-time PCR, as 
described previously13. 
CFSE suppression of proliferation assay 
A proliferation suppression assay was performed utilising coculture of 
magnetically isolated CFSE-stained target non-Treg cells with 
magnetically isolated Treg. EasySep™ Human CD4+CD127lowCD25+ 
Regulatory T Cell Isolation Kit (StemCell Technologies) was used to 
obtain Tregs and target cells from cord blood mononuclear cells. The 
target cells were stained with 5 μM CFSE, plated into 48-well plates with 
6 
 
or without Tregs and cultivated for 72 hours. 20 ng of recombinant human 
IL-2 (PeproTech), 1 μg of purified, functional grade human anti-CD3 
(ThermoFisherScientific) and 1 μg of purified, functional grade human 
anti-CD28 (ThermoFisherScientific) were added per 106 target cells to 
stimulate proliferation. 0.5×106 cells in total were seeded in each well. 
After 72h, cells were stained for CD4 and analysed with flow cytometer. 
Statistics 
Data were evaluated using unpaired Student’s t-test in case of data 
with normal distribution and non-parametric Mann-Whitney test for the 
rest of the data. 
4. Results 
Distinct characteristics of Tregs of newborns of healthy and allergic 
mothers. 
Černý, V., Hrdý, J., Novotná, O., Petrásková, P., Boráková, K., 
Kolářová, L., Prokešová, L. PLoS ONE (2018) 13(11): e0207998. 
https://doi.org/10.1371/journal.pone.0207998 
The goal of this work was to evaluate whether any differences could 
be found in the population and phenotypic characteristics of Treg in cord 
blood of children of allergic mothers and cord blood of children of healthy 
mothers. 
Evaluation of cord blood Treg, iTreg and nTreg populations by flow 
cytometry 
Percentage of CD4+CD25+CD127lowFoxP3+ Treg in CD4+ cells was 
significantly higher in children of allergic mothers than in the low-risk 
group. Furthermore, the children of healthy mothers had significantly 
higher proportion of Helios- iTreg among Treg. These findings might hint 
at a delayed immune maturation and iTreg formation in the high-risk 
group, which could potentially contribute to the increased risk of allergy. 
Determination of selected phenotypic characteristics associated with 
Treg regulatory function 
Significantly higher proportion of PD-1+ Treg was observed in cord 
blood of children of healthy mothers, with a similar albeit non-significant 
trend discernible for CTLA-4+ Treg. Furthermore, children of healthy 
mothers had significantly higher percentage of IL-10+ Treg in cord blood. 
Taken together, markers associated with Treg function are observably 
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lower in the high-risk group, potentially hinting at a compromised 
regulatory function. 
Assessment of Treg regulatory function 
We performed a functional assay based on cocultivation of Treg 
isolated from cord blood with CFSE-stained non-Treg (CD4+CD25-) 
conventional T cells. We observed lower ability of cord blood Treg of 
children of allergic mothers to inhibit proliferation of conventional 
T cells, hinting at defective suppressive function of Treg in the high-risk 
group. Furthermore, levels of IL-10 and TGF-β were significantly lower 
in cord blood plasma of children of allergic mothers, further pointing to a 
dysregulated pattern of immune regulation in the high-risk group. 
The results exposed impaired regulatory capabilities of cord blood 
Treg of children of allergic mothers that may play a role in the higher 
risk of allergy described in literature. Another interesting finding is 
that children from the high-risk group have lower proportion of 
iTreg among their Treg. We hypothesise that our data reflect 
dysregulated development of Treg in children of allergic mothers, 
potentially due to delayed maturation of their immune system. The 
counterintuitively higher percentage of total Treg among CD4+ 
T cells in the high-risk group may be due to a compensatory 
expansion. 
 
Value of cord blood Treg population properties and function-
associated characteristics for predicting allergy development in 
childhood. 
Černý, V., Hrdý, J., Novotná, O., Petrásková, P., Boráková, K., 
Kolářová, L., and Prokešová, L. (accepted for publication in CEJI, 2019) 
In this follow-up study, we compared cord blood Treg population 
properties and phenotypic characteristics, measured at the time of birth11, 
among children divided into two groups according to their allergic status 
at the age of 6–10 years. Healthy and allergic children were further 
subdivided into four groups according to the risk of allergy predicted at 
birth by maternal allergy status.  
Proportion characteristics of cord blood Treg in allergic and healthy 
children 
While no differences were observed in percentage of 
CD4+CD25+CD127low Treg among neither the two basic groups nor the 
four subgroups, significantly higher percentage of CD4+CD25+ T cells 
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(including Treg but potentially also activated T cells) was found in the 
group of healthy children. Upon subdivision according to maternal 
allergy status, the group of healthy children of healthy mothers, i.e. 
healthy children from the low-risk group, showed a higher percentage of 
these cells than both healthy children of allergic mothers and allergic 
children of healthy mothers. 
Treg phenotypical characteristics and intracellular presence of 
immunoregulatory cytokines in Treg of allergic and healthy children  
No difference was observed in FoxP3 MFI among the groups in the 
current study. Upon subdivision according to maternal allergy status, 
significantly higher proportion of IL-10+ Treg was uncovered in healthy 
children of healthy mothers and conversely, a significantly lower 
proportion of TGF-β+ cells was discernible in allergic children of allergic 
mothers.  
Concentration of cytokines with regulatory functions in plasma of 
cord blood 
Healthy children of healthy mothers exhibited significantly higher 
serum concentration of IL-10 than allergic children of allergic mothers, 
as well as significantly higher levels of TGF-β than both groups of 
children of allergic mothers. 
The results of this study support the notion that analyses of 
functional aspects of Treg might have greater predictive value than 
simply determining population proportions. Differences observed 
between the original study and the follow-up stress the importance of 
maintaining sufficient cohort sizes, as limiting the analysis to a 
selection from a larger cohort may influence the results, contributing 
to numerous discrepancies observed between published studies. 
 
Decreased allergy incidence in children supplemented with E. coli 
O83:K24:H31 and its possible modes of action. 
Hrdý, J., Vlasáková, K., Černý, V., Súkeníková, L., Novotná, O., 
Petrásková, P., Boráková, K., Lodinová-Žádníková, R., Kolářová, L., 
and Prokešová, L.  Eur. J. Immunol. (2018) 48(12): 2015–2030. 
https://doi.org/10.1002/eji.201847636 
This study reports lower allergy incidence at the age of 8 years in 
infants of allergic mothers supplemented early postnatally with EcO83. 
Immunological characteristics including Treg population proportions and 
regulatory cytokine profiles at the age of 8 years were followed. In 
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addition, effect of in vitro stimulation of cord blood mononuclear cells 
(CBMC) with EcO83 was tested. 
The children were originally divided into three groups: children of 
allergic mothers colonised with EcO83 during the first days of life; 
non-colonised children of allergic mothers; and non-colonised children of 
healthy mothers. At the age of 8 years, the three basic groups were further 
subdivided according to the children’s allergy status determined by 
allergist examination into six groups in total. 
Effect of EcO83 supplementation on allergy incidence and regulation 
Colonised children of allergic mothers had lower incidence of allergy 
than non-supplemented children of allergic mothers, reaching incidence 
observed in low-risk group of children of healthy mothers. No difference 
of total Treg population was observed. However, healthy children had 
significantly higher proportion of Helios- iTreg, regardless of maternal 
allergy status. This increase was driven by higher percentage in the group 
of colonised children, particularly those who did not develop allergy. 
Allergy-associated differences in cytokine profiles in colonised and 
non-colonised 8-year-old children 
Quantification of plasma IFN-γ and IL-10 by ELISA revealed 
significantly higher levels of both cytokines in children of healthy 
mothers and colonised children of allergic mothers, compared with 
non-colonised children of allergic mothers. Generally, healthy children 
had highest levels of IFN-γ and IL-10; however, healthy non-colonised 
children of allergic mothers had lower levels than the other two healthy 
groups, hinting at less developed regulatory mechanisms preventing Th2 
immune response activation in the untreated high-risk group even in 
absence of overt disease. We observed significantly higher proportion of 
IL-10+ Treg as well as CD4+FoxP3- cells (putative Tr1) in the blood of 
children of healthy mothers and colonised children of allergic mothers. 
Collectively, the observed patterns of cytokine production are 
consistent with the known preventive effect of EcO83 supplementation 
and might represent a possible immunoregulatory mechanism underlying 
this phenomenon. 
Biological effects of stimulation of CBMC by EcO83 
In order to elucidate the possible mechanisms involved in EcO83 
probiotic function, we investigated the effect of in vitro stimulation by 
the strain on cytokine production by mononuclear cells isolated from cord 
blood of children of allergic and of healthy mothers. No changes in gene 
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expression of IL-4 were present, regardless of the stimulation or of 
maternal allergy status. Gene expression of IFN-γ was significantly lower 
in unstimulated controls than in CBMC stimulated by EcO83, EcN and 
LPS; the difference remained significant even after subdividing the 
subjects according to maternal allergy status, except in the case of 
stimulation of CBMC of children of allergic mothers by EcN. Gene 
expression of the regulatory cytokine IL-10 determined by qPCR was 
significantly increased after culture with all three stimulants; importantly, 
stimulation of CBMC by EcO83 led to significantly higher upregulation 
of IL-10 expression than stimulation with LPS and EcN. This pattern was 
also found in the subgroup of children of healthy mothers, while in 
children of allergic mothers, only CBMC cocultured with EcO83 and LPS 
upregulated IL-10 gene expression. 
CBMC cocultured with LPS and EcO83 produced significantly higher 
amounts of IFN-γ into the supernatant than unstimulated cells or cells 
stimulated with EcN. Importantly, stimulation of CBMC by EcO83 
induced significantly more IL-10 than all the other conditions. After 
division of CBMC according to the mothers’ allergic status, significantly 
increased IL-10 levels were detected after all three modes of stimulation 
in CBMC both groups. Moreover, CBMC of children of allergic mothers 
stimulated by EcO83 produced significantly more IL-10 than 
corresponding cells stimulated by LPS or EcN. 
Results of this study further corroborate the potential of probiotic 
E. coli strain O83:K24:H31 for allergy prevention. Higher 
proportion of iTreg in the colonised group supports the hypothesis 
that probiotic supplementation with EcO83 promotes tolerogenic 
environment necessary for mitigation of allergy development in the 
high-risk group. While colonisation had no effect on IL-4 production, 
colonised children of allergic mothers exhibited significantly larger 
proportion of IL-10+ Treg and non-Treg CD4+ T cells and higher 
levels of IFN-γ and IL-10 in serum, reaching levels found in the 
low-risk group. Increased production of IFN-γ and IL-10 could help 






Different capacity of in vitro generated myeloid dendritic cells of 
newborns of healthy and allergic mothers to respond to probiotic 
strain E. coli O83:K24:H31. 
Súkeníková, L., Černý, V., Novotná, O., Petrásková, P., Boráková, 
K., Kolářová, L., Prokešová, L., and Hrdý, J. Immunol. Lett. (2017) 
189, 82–89. https://doi.org/10.1016/j.imlet.2017.05.013 
Responsiveness of monocyte-derived DC generated in vitro from cord 
blood of children of allergic and healthy mothers to EcO83 
Surface expression of activation marker CD83 was significantly 
upregulated after culture with EcO83 and LPS. Furthermore, moDC from 
allergic mothers had significantly higher CD83 than moDC from healthy 
mothers, regardless of stimulation, implying higher reactivity in the 
high-risk group. Unstimulated moDC derived from CBMC of healthy 
mothers had significantly higher gene expression of both IDO and IL-10 
than unstimulated moDC from CBMC of children of allergic mothers. 
After stimulation with EcO83, gene expression of IDO was significantly 
upregulated in both low-risk and high-risk group, reaching comparable 
levels. While the expression of IL-10 likewise increased in both 
stimulated groups compared to the respective unstimulated moDC, the 
upregulation was significantly more pronounced in moDC derived from 
CBMC of children of healthy mothers, possibly indicating impaired 
regulatory function in the high-risk group of children of allergic mothers. 
Levels of inflammatory cytokines TNF-α and IL-6 were increased after 
stimulation with EcO83 and LPS. While IL-10 was likewise significantly 
upregulated upon culture with LPS and EcO83 in moDC from children of 
both healthy and allergic mothers, the increase was significantly higher 
when moDC from the low-risk group were stimulated with EcO83, 
compared both with stimulation by LPS and with stimulation of moDC 
from allergic mothers by EcO83. Taken together, the data imply that 
moDC derived from children of allergic mothers show higher reactivity 
and activate upon microbial stimulation more strongly but show signs of 
regulatory deficiency. 
Induction of Th responses by probiotic primed moDC 
No difference in the percentage of FoxP3+ Treg was observed upon 
coculture with moDC, regardless of maternal allergy status or microbial 
stimulation; however, moDC stimulated with EcO83 were able to induce 
significantly larger proportion of IL-10+ CD4+ T cells than non-stimulated 
moDC. Surprisingly, significantly higher percentage of IL-10+ cells was 
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also present after CD4+ T cell coculture with moDC derived from CBMC 
of children of allergic mothers compared with moDC from CBMC of 
children of healthy mothers. 
The data in this study uncovered higher expression of activation 
markers, greater capacity to induce inflammatory Th responses and 
overall increased reactivity of moDC derived in vitro from 
mononuclear cells isolated from the cord blood of children of allergic 
mothers, combined with impaired expression of regulatory factors 
such as IDO and IL-10. Stimulation with EcO83 promoted regulatory 
function of moDC in a complex fashion, increasing both regulatory 
IL-10 and inflammatory IL-6 and TNF-α. The upregulation of 
tolerogenic markers was more pronounced in moDC generated from 
CBMC isolated from children of healthy mothers. The results 
indicate that DC of children of the low-risk group are better equipped 
to induce tolerogenic responses upon encounter with innocuous 
environmental stimuli, including probiotic bacteria. Moreover, we 
have demonstrated that EcO83 is capable of promoting the 
upregulation of regulatory mechanisms in DC, possibly an important 
mechanism of its probiotic effect. 
5. Discussion 
In our work, we aimed to gain more insight into early processes in 
allergy development by comparing the role of Treg and their 
subpopulations in cord blood of children with higher and lower expected 
risk of allergy development. We also described in vivo and in vitro effects 
of probiotic E. coli strain EcO83 to help improve our understanding of 
the mechanisms by which probiotic bacteria can promote immune 
homeostasis. 
In cord blood of children of allergic mothers we observed larger total 
proportion of Treg. Nevertheless, this group had fewer Helios- induced 
Treg in cord blood than children of healthy mothers. In addition, smaller 
proportions of PD-1+ and IL-10+ Treg cells were present in cord blood of 
high-risk children, with similar trends noticeable for CTLA-4+ and 
TGF-β+ Treg. These observations hint at impaired or immature functional 
capacity of Treg in the high-risk group; the increase of total Treg in CD4+ 
T cell population might result from compensatory upregulation. iTreg 
arise in peripheral lymphoid tissues after exposure to environmental 
factors and are crucial in allergy control. Higher iTreg proportion may 
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reflect more matured immune system of the low-risk children at birth, 
contributing to control of allergy. 
Analysing a different cohort of older children, we compared actual 
allergy development with subpopulation proportions and functional 
properties of cord blood Treg originally described by our group in 201211. 
Main findings include higher proportion of IL-10+ Treg in healthy 
children of healthy mothers and lower TGF-β in allergic children of 
allergic mothers, reflecting the role of these cytokines in allergy control. 
We also observed increased proportion of CD4+CD25+ cells in peripheral 
blood of healthy children of healthy mothers, but no difference in children 
of allergic mothers (Černý et al., accepted for publication in CEJI, 2019). 
As CD4+CD25+ cells include both Treg and activated conventional 
T cells15, this observation may point to a differential composition or 
functional role of this cell population between the high-risk and low-risk 
groups at birth. Children of allergic mothers have been described to be 
overall more prone to immune activation12,16, CD4+CD25+ cells might 
thus include higher ratio of activated non-Treg cells to Treg in this group.  
We observed higher expression of activation marker CD83 on DC 
generated from CBMC of children of allergic mothers compared to 
children of healthy mothers, coupled with lower expression of regulation-
associated genes (IDO, IL-10) and greater reactivity of these cells to 
stimulation by EcO83. DC of the high-risk neonates are thus more prone 
to immune activation and less tolerogenic. This is in line with the 
hypothesis that an insufficiency of immune regulatory mechanisms 
contributes to the increased risk of allergy. 
Various groups have attempted to elucidate the role of Treg in allergy 
development, with inconsistent results. Some groups report increased 
Treg proportions in cord blood of children with higher risk of 
allergy11,17,18, while in other studies opposite trend was observed19 or no 
differences were found20. Various factors could explain this 
inconclusiveness. Genetic background and environment combine to 
determine allergy development, therefore data from different populations 
will vary, particularly between studies carried out in urban17 vs. farming 
environment18. 
Furthermore, for Treg identification to be comparable among studies, 
gating strategy and the choice of markers need to be carefully 
considered11. Identifying Treg as CD4+CD25+ cells is especially 
problematic, as CD25 is upregulated in effector T cells15 and CD4+CD25+ 
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cells will invariably include activated non-Treg. The very highest CD25 
expression correlates better with the regulatory characteristics than 
simple CD25 positivity21, so Treg should be identified as CD25high cells. 
Transient FoxP3 upregulation has been described in activated Tconv15. 
As we have observed higher tendency towards immune activation in 
children of allergic mothers12,16, cells described as Treg in this group 
might in fact contain larger proportion of recently activated non-Treg 
CD4+ T cells. Furthermore, choice of clone of monoclonal antibodies 
used for FoxP3 staining is of paramount importance. Using different 
clones can provide different estimates of Treg proportions or identify 
Treg subpopulations with different effectiveness22,23.  
Among Treg subpopulations, iTreg are particularly important for oral 
tolerance and allergy control as they arise upon harmless antigen 
recognition in periphery. So far, no indisputable markers have been 
proposed for iTreg identification. Expression of transcription factor 
Helios has been proposed as a marker of thymus-derived nTreg24, with 
peripherally generated iTreg being Helios-. The suitability of Helios as an 
exclusive marker of nTreg has been questioned by various studies25,26, 
though the issue is yet to be resolved27. Alternative explanations of Helios 
biological role have been proposed, including its upregulation in T cells 
upon activation25. In such case, the observed higher proportion of Helios+ 
Treg in the high-risk group might again reflect higher tendency toward 
immune activation and inflammation. Alternatively, Helios was proposed 
to control Treg development and acquisition of stable regulatory 
phenotype28. Upregulation of Helios might then in fact be a sign of the 
compensatory expansion of Treg.  
Considering the issues mentioned above, it follows that analysis of 
characteristics associated with Treg function will give more reliable 
information than simple enumeration of these cells or their 
subpopulations. Treg function can be assessed indirectly by estimating 
presence of relevant surface markers with immunoregulatory functions or 
regulatory cytokines, or directly using assays based on coculture with 
CFSE-stained or radioactive 3H-thymidine labelled target cells. 
CTLA-4 and PD-1 are the most important co-inhibitor molecules 
involved in Treg function29 and play an indispensable role in contact-
dependent suppression mediated by Treg, evidenced by various 
autoimmune and lymphoproliferative syndromes associated with 
deficiency of these molecules30. CTLA-4 has been implicated in food 
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allergy31 and regulating the Th1/Th2 crosstalk in asthma32. PD-1 has been 
shown to control asthma in animal models33. 
IL-10 and TGF-β are chief immunoregulatory cytokines, and their 
importance for allergy control is universally accepted34. IL-10 production 
by Treg and FoxP3- CD4+ Tr1 cells is indispensable for the success of 
allergen-specific immunotherapy35. TGF-β supports mucosal 
homeostasis and generation of iTreg, playing a key part in oral 
tolerance36. 
Our observations (decreased expression of PD-1, lower production of 
IL-10, impaired suppressive ability estimated by a coculture-based assay) 
unveil compromised Treg function in children of allergic mothers. This 
defect in suppressive activity of Treg may explain our previous 
observations of exaggerated immune reactivity in the high-risk group12,16 
and may be a major cause of the higher risk of allergy development in this 
group. 
Probiotic treatment offers a promising possibility of intervention, 
although the optimal microbial strains and mode of supplementation for 
such use are yet to be conclusively established. In our study, we describe 
the effects of early postnatal administration of probiotic E. coli strain 
O83:K24:H31 in a prospectively followed cohort of colonised children of 
allergic mothers, compared with non-supplemented children of allergic 
mothers and non-supplemented children of healthy mothers. Current 
report describes allergy status and relevant immune characteristics at the 
age of 8 years. In the supplemented group of high-risk children we 
observed lower incidence of allergic diseases, comparable with the 
incidence in the low-risk group. This was likely due to the effect on Treg: 
colonised children had more induced Treg than both other groups. 
Supplementation of high-risk children with EcO83 increased production 
of IL-10. The cytokine production reached the levels seen in children 
belonging to the low-risk group, with an equally strong upregulation 
observed for IFN-γ. 
We also determined the effect of stimulation by EcO83 on cells 
isolated from cord blood. In one study, we observed increased expression 
of IL-10 and IFN-γ in CBMC. We further tested the effect of EcO83 
stimulation on moDC generated in vitro from CBMC in order to see if 
promoting adequately polarising antigen presentation might play a role in 
EcO83 probiotic effect. We describe a complex stimulatory effect of 
EcO83 on model DC: upregulation of CD83, gene expression of IL-10 
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and IDO as well as release of IL-10, IL-6 and TNF-α. Importantly, DC of 
children of healthy mothers upregulated IL-10 production to a 
significantly greater degree, implying higher tolerogenic capacity in the 
low-risk group. EcO83 stimulated DC of the low-risk group were also 
able to induce more IL-10+ CD4+ T cells upon coculture, illustrating the 
more robust immune regulation present in the low-risk children. 
Biological effects of probiotic supplementation are highly strain 
specific. In our study, we demonstrate that the key effect of EcO83 
administration in the context of allergy is likely its ability to promote 
IL-10 production by Treg and Tr1 as well as Th1 response. Induction of 
Treg by various probiotic bacteria has been described by many studies so 
far37–40. Furthermore, the effect of EcO83 is apparently mediated through 
the priming of neonatal DC toward Treg induction, similar to reports of 
other groups38,41. 
The data regarding probiotic use in prevention of allergy remain 
inconclusive and further studies coupled with rigorously performed meta-
analyses need to be carried out to determine most beneficial strains. 
Likewise, conditions such as timing, mode of application and dosage need 
to be optimised for maximal beneficial effect, with combined prenatal and 
early postnatal supplementation being proposed by current guidelines42. 
So far, the most persuasive arguments have been made for probiotic use 
in atopic dermatitis prevention10,42, with the benefit of probiotics in other 
forms of allergy being hotly debated43. 
In this thesis, we described a broadly preventive effect of EcO83 in 
allergy lasting up to the age of eight years44. We propose that this effect 
is likely at least in part mediated via inducing maturation of DC, which 
leads to increased support of Treg and Th1 responses and a long-term 
increase in IL-10 and IFN-γ production in the treated neonates, helping 
the immune system to rebalance away from prenatal dominance of Th2 
response. Supplementation with EcO83 seems like a useful approach for 
allergy prevention in the groups with higher risk of allergy. 
6. Conclusions 
6.1. We analysed population proportions and functionally-relevant 
characteristics of Treg in cord blood of children of allergic mothers. 
a) Children of allergic mothers (with higher risk of allergy 
development) had larger proportion of total Treg population 
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among CD4+ T cells. They also had larger Helios+ nTreg fraction, 
while the percentage of Helios- iTreg among total Treg was lower 
than iTreg proportion among Treg of children of healthy mothers. 
b) Children of allergic mothers exhibit lower percentage of PD-1+ 
and IL-10+ cells among Treg, lower cord blood plasma levels of 
IL-10 and TGF-β, and impaired Treg suppressive function. We 
observed higher expression of activation marker CD83 on moDC 
from children of allergic mothers, as well as higher ability to 
induce T cell polarization to Th1, Th2 or Th17 branches upon 
coculture. 
c) Proportion of CD4+CD25+ T cells was higher in healthy children 
of healthy mothers compared with allergic children of healthy 
mothers, but no difference was observed between healthy and 
allergic children of allergic mothers, hinting at different 
composition or role of this population between the high-risk and 
low-risk group. Healthy children of healthy mothers showed 
increased IL-10 and TGF-β production and allergic children of 
allergic mothers had decreased TGF-β at birth. 
Our data supports the hypothesis that children of allergic 
mothers have delayed functional maturation of regulatory T cells in 
the perinatal period, reflected in decreased presence of markers 
associated with function, lower cord blood plasma levels of IL-10 and 
TGF-β and lower numbers of induced Treg. This may be linked with 
the higher immune reactivity of moDC derived from CBMC of 
children of allergic mothers. 
Analysis of function-associated markers of Treg and direct 
analyses of regulatory function will likely be more useful for 
improving our understanding of early phases of allergy development 
than simple analysis of Treg proportion in circulatory CD4+ T cells. 
6.2. We evaluated effects of early postnatal supplementation of children 
of allergic mothers with EcO83 on immune system at the age of 8 years. 
Furthermore, we analysed the effect of in vitro stimulation with EcO83 
on CBMC and moDC. 
a) We observed decreased incidence of allergy at the age of 8 years 
in the group colonised with EcO83. Colonised children had more 
Helios- iTreg at the age of 8 years As iTreg generation occurs 
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mostly in mucosal peripheral tissues and iTreg include cells with 
TCR specific for allergens, colonisation with EcO83 may favour 
more robust control of unwarranted reactivity against exogenous 
antigens, including Th2-mediated allergy. 
b) Production of IL-10 and IFN-γ was substantially increased in 
supplemented children of allergic mothers at the age of 8 years. 
Concentration of IL-10 and IFN-γ reached levels found in the 
low-risk children. 
c) Stimulation of CBMC with EcO83 strongly induced expression 
of IL-10 and IFN-γ in CBMC. EcO83 stimulation led to 
upregulation of CD83 on moDC and induced expression of 
regulatory effector molecules IDO and IL-10. moDC derived 
from CBMC of children of healthy mothers stimulated with 
EcO83 were able to induce production of IL-10 in CD4+ T cells. 
Early postnatal EcO83 supplementation induces long-term 
regulatory effects in the high-risk children, leading to a decrease in 
allergy incidence at the age of 8 years. Increased IL-10 and IFN-γ 
together with more appropriately polarizing antigen presentation by 
stimulated DC may help set up immunoregulatory conditions in the 
infant necessary for rebalancing immune polarization away from the 
prenatal Th2 bias.  
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